Target Discovery
Ready-to-use AI-driven applications to discover and evaluate predicted novel targets to improve preclinical pipeline performance
Novel targets to drive the preclinical pipeline
We work closely with many pharmaceutical & biotech companies to accelerate and de-risk their Target discovery process. Euretos' computational, AI-driven disease models predict novel target associations that domain experts can evaluate rapidly using our AI-integrated knowledge base.
Data-driven, novel target candidates
We support purchasing via scientist.com and science exchange!
Maximise target discovery potential
Empower your domain experts to evaluate target predictions
360 degree biological, functional and commercial target evaluation
Rapid onboarding
Keep up with our latest news and events. Sign up for our newsletter.